All Stories

  1. Association between expression of MMP-2 and MMP-9 genes and pathogenesis of intracranial hemorrhage in severe coagulation factor XIII deficiency

    Article • Hematology, December 2014, Taylor & Francis

    Dr Akbar Dorgalaleh

  2. Central nervous system bleeding in pediatric patients with factor XIII deficiency: A study on 23 new cases

    Article • Hematology, July 2014, Taylor & Francis

    Dr Akbar Dorgalaleh, Shadi Tabibin

  3. C0105: Plasminogen Activator Inhibitor-1 Polymorphism is Not Associated with Central Nervous System Bleeding in Pediatric Patients with Factor XIII Deficiency

    Article • Thrombosis Research, May 2014, Elsevier

    Dr Akbar Dorgalaleh

  4. Biochezmical Interfering Factors and Blood Cells Indices

    Article • Thrita, March 2014, Kowsar Medical Institute

    Dr Akbar Dorgalaleh, Shadi Tabibin

  5. Evaluation of complement regulatory components in patients with atypical hemolytic uremic syndrome

    Article • Central European Journal of Immunology, January 2014, Termedia Sp. z.o.o.

    Dr Akbar Dorgalaleh

  6. Frequency of β-Thalassemia or β-Hemoglobinopathy Carriers Simultaneously Affected with α-Thalassemia in Iran

    Article • Clinical Laboratory, January 2014, Clinical Laboratory Publications

    Dr Akbar Dorgalaleh, Dr Fakher Rahim, Professor Najmaldin Saki

  7. Polymorphism of thrombin‐activatable fibrinolysis inhibitor and risk of intracranial haemorrhage in factor XIII deficiency

    Article • Haemophilia, October 2013, Wiley

    Dr Akbar Dorgalaleh, Shadi Tabibin

  8. A Prospective Study of Tubular Dysfunction in Pediatric Patients with Beta Thalassemia Major Receiving Deferasirox

    Article • Pediatric Hematology and Oncology, October 2013, Taylor & Francis

    Dr Akbar Dorgalaleh, Shadi Tabibin

  9. Safety of human blood products in rare bleeding disorders in southeast of Iran

    Article • Haemophilia, December 2012, Wiley

    Dr Akbar Dorgalaleh